Guidelines & Advice

Treatment

Treatment is determined by the type and stage of cancer, as well as by what treatments and services a patient chooses. The guidelines and other documents available here focus on topics related to the treatment of cancer in Ontario.

Multidisciplinary Cancer Conferences

Displaying Guidelines

54 Items

Cancer Care Ontario’s Focus on Take-Home Cancer Drugs and Community Practice

Document Status: Current
ID: GL-C50-17

Jan 2015

Clinical Verification of Cancer Drug Prescriptions Checklist: Cancer Centres and Specialty Pharmacies

Document Status: Current
ID: GL-C50-18

Jan 2015

Computerized Prescriber Order Entry (CPOE) in the Outpatient Oncology Setting

Document Status: Current
ID: 12-14

May 2012

Continuous versus Intermittent Chemotherapy Strategies in Inoperable, Advanced Colorectal Cancer

Document Status: Current
ID: 2-6
Version: 2

Sep 2022

Enhancing the Delivery of Oncology Systemic Treatment in the Home and Community in Ontario Recommendations Report

Document Status: Current
Version: 1

Feb 2022

Enhancing the Delivery of Take-Home Cancer Drugs in Ontario

Document Status: Current

Mar 2019

Fluoropyrimidine Treatment in Patients with Dihydropyrimidine Dehydrogenase (DPD) Deficiency: Guidance for Clinicians

Document Status: Current
Version: 1

Apr 2023

Guidance on the Substitution of Systemic Therapy Agents

Document Status: Current
ID: GL-C50-33
Version: 1

Aug 2017

Hepatitis B Virus Screening and Management for Patients Receiving Systemic Treatment

Document Status: Current

Sep 2022

Indications for Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery

Document Status: Current
ID: GL 17-12
Version: N/A

Sep 2019

Kadcyla® Trastuzumab Emtansine Safety Reminder

Document Status: Current
ID: GL-C50-15

Jun 2014

Locoregional Management of In-Transit Metastasis in Melanoma

Document Status: Current
ID: GL 8-10
Version: N/A

Feb 2020